Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Clinical trial NCT05764265 · TERMINATED
Trial details
- NCT number
- NCT05764265
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2024-04-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.